Solent Multiple Sclerosis Therapies Limited Flnancial A¢nts for the Perlod Ended 31 MaTch 2026 Company Registsatlon Number: 2215154
Solent Multiple Sclerosis Therapies Limited Report and Accounts for the Period Ended 31 March 2026 CONTENTS PAGES Report of the Directors Independent Examinerfs Report Stslement of Financial Acbvittes Income and Expendrture Account Batan¢e Sheet Notes lo the Acuunts 7-10 The folkhytng pages do not fomi part of statutory accounts. Summary Income arKI Expendttijre Account Income Detsil 12 PhySl0Ste0IRefieX1ShIatsU anaty&"s 13 Bank Balances 14 Fixed Assels 15 Detailed Irrtc*rte and ExpendrtUTe Aeeount 16
Solent Multiple Sclerosis Therapies Limited Accounts for the Period Ended 31 March 2026 Trustee5 R Hayter - Acting Chaimian A Alexander A Sandford R MooThen K Ebbens K Silman L Rtckman C Alexander Registered Office Bradbury House 56 Hewett Road North End Portsmoyth Hampshire P02 OQP Bankers Lloyds TSB plc 16A High Street Cosham Portsmouth Hampshire P06 3BY Company Number 2215154 Accounlanls Hunter Simmons Ltd 3a London Road Purbrook Walerlooville Hampshire P07 5LQ
Solent Multiple Sclerosis Therapies Limited Report of the Directors for the Period Ended 31 March 2026 Report of the Directors The directors herwth present the aCnIS for the period ended 31 March 2026. ActSvfties of the Company The companls principal aclNty is to aid the condikn.on of those suffering from rnUtt¥) sclerosis by PiOVKling guidance, practical support and therapy lo those such pens. Directors The directors of the company throUght the yearwere as frAkM.' A Sandford A Alexander R Moorhen L Rt¢km8n R HaY(er K Silman L Clarke (Reswned 18.07.25) C thxander K Ebbens IReswJned 11.01.26) S Emery (Resoned 02.06.251 The directors do not hokl any shares in Ihe cc¥npany. Charitable Status The company is a registered Charty with the Charity cmisSiOnerS in England and Wales. Company Number and Charlty Numbel The company regisler&J number is 2215154 and the Regi8ter&J Charity number is 299545. Govgrning Document The goveming document is the MemorandL¢m atMI Articles of Assock4tion. Trustees The directors have produ¢ed a DirectOTS' Report as required by Company Law instead of a Tiuslees, ReporL Rggi$tered Office The fegislered office of the ch*ty is Bradbury House. % Hewett Road, North Etxl, Portsmothh, Hampshire P02 QQP. Exemptlons Advantage has been taken in the preparation of the Directors, Rewt of the special exemptions applicable to small companies conferred by Part 15 of the Companies Act 2006. y Orde of the Boar ..R Hayter- Chaifman
Independent Examiner's Report to the Trustees of Solent Multiple Sclerosis Therapies Limited I report to the charty trust$ on my eXamatIOn of the acccHJnts of the Cmipany fof the year ended 31 M8r¢h 2026. ResponsibilitTe5 and basis of report As the Iruslees of the Charty {8nd also its directors for the purposes of ccmxpany lawl you are responsible for the preparatKJn ol the accounts in accordance with the requirements of the Companies Act 20( I'the 21K% Acri. Having satisfied myself that the accounts of the Ci)mpany are nol required lo be audrted under Part 16 of the 2006 Act are eligible for indepersdent examinatw)rF, I report in respect of my examination of your charivs accounts as Carried oul under sectton 145 of the Chartties Act 2011 {'Ihe 2011 Act'l. In carryng out my examination I have folkn¥ed the DirectKffls gNen by the Charity Cornmission under section 145(51 {bl of the 2011 ACL Indapendent examinerfs statement I have completed my exarninalion. I confi that rKJ rnatteT5 have come to my attention in connection with the examination giving me cause to beIve.. accounting COrdS We nol kept in re$t of the Company as requwed by sect¢on 386 of the 201% A¢( or the accounts do not accoTd wth those records., or the accounts do not compty with the accountirwa qu1mentS of section 396 of the 2006 Act other than any reqLfirement that that accounts give a true and fair view which is not a matter considered as part of an independent exarninatn. or the 8¢counls have not been prepared in accordance with the methcxls and princpks ofthe Slalemenl of Recommended Prath"ce for accounting and reporting by CharitS lapplicable lo charities preparing their accounts in acwrdanGe wilh the Financial Reporting Stsndard applicable in the UK and Republi¢ of Ireland IFRS 10211 I have no concems and have come acFOSS no other matters in connection with the examÈnatK)n to which attention should be drawn in this report in orderto enable a proper understanding ol the accounts lo be re¥h. Sean Hunter, FFP FIPA Institute of Financial Accountants Membership Number". 232174 Hunter Simmons Ltd 3a London Road Purbrook Waterlcoville Hampshire P07 5LQ If MA1 2L7LL
Solent Multiple Sclerosis Therapies Limited ststement of Financial Activities For the Period Ended 31 MarGh 2026 Notes Mar-26 Mar-25 General Fund Incomlng Resources: Don81ions'. Donalions and Grfts 132.5( 155.102 Investment Income Income from trading activrties.. Related lo 0.¢¢ts of the charity 1,087 1,209 Total incoming reurCeS 133.593 156.311 Resources Expended: Direct Charitable Expenditure Fund Raising and Publscty Management and Administration 54.507 7,924 98.369 56,545 11,390 99,763 Total resources expended 160,800 167,698 Net incoming resources {27.2071 {11.3871 Balances at 31 March 2025 331.898 343.285 Balances at 31 March 2026 304.691 331,898
Solent Multiple Sclerosis Therapies Limited Income and Expenditure Account For the Period Ended 31 Mar¢h 2026 Mar-26 Mar-25 Total Income frMI continuing operat*)ns 133.593 156.311 Total expenditure from continuing opationS 160,800 167,698 Net incomel{expenditure) for the year 27.20 11,387 There are no recognised gains or losses in 2026 or 2025 other than the net income forthe years. The notes on pages 7 to 10 fomi part of these accounts
Solent Multiple Sclerosis Therapies Limited Balance Sheet As at 31 March 2026 Mar-26 May-25 Flxod A$$ets Tangible Assets 202,931 209,416 Current Assets Stocks Prepayments Cash al Bank and in Hanfl 3,945 120,738 124,683 3.261 146.591 149.852 Creditors: Amounts duè wlthin one year Other creditors 10 3,835 8.282 Net Current Assets 120.848 141,570 Total Net Assets 323,779 350,986 Fund Balances Income and Expenditure Account 304.691 331,898 Reserv Caprtal 3,200 3,200 Operating Reserve Accwnt 15.888 15,888 Total Fund Balances 323.779 350,986 The Balan Sheel continues on the fdlowrng page The notes on pages 7 10 10 fomi part of these accounts
Solent Multiple Sclerosis Therapies Limited Balance Sheet {continued As at 31 March 2026 Dlre¢toYs' Statgment The company is enlrtled to exernptvJn from audrt under Section 477 of the Compan$ Act 2006 rdaling lo small companies. lof the pericl ended 31 Mareh 2026. The members have not Tequired the company lo obtain an audit of its financial statements for the perirxl ended 31 March 2026 in accordance with Seclvjn 476 of the Companies Act 2tIO6. The dire¢lors acknohvledge thr resp0nsts1frt for.. {a} ensLEring thal the company keeps Counting records v&hich complyth SectIs 386 and 387 of the Companies Act 21X and b} preparing financial statements which give a true and fair view of the slate of affairs of the cLympany as at the end of each financial year and of rts profft or loss for each financial year In accordance with the requirements of Sect)ns 394 and 395 and which otheThvise cL¥npty wrth the requirements of the Companies ACE 20C6 relaling lo financial statements. so fai as applicable lo the compar7y. The accounts h8ve been prepared in accordance wth the special pro)risions of Part 15 of the Companies Act 2006 Telaing lo small companies and with the Financial Reporting Standard for Smaller Efttilies (effective Apfil 2008}. These accounts were approved on.............. .. R Hafv- Director .. L Rickman- DKe¢tor The notes oll pages 7 to 10 foim part of these accounts
Solent Multiple S¢lerosis Therapies Limited Notes to the Accounts For the Pertod Ended 31 March 2026 ACCOUNTING POUCIES 8asis of Accounting These acConts have been prepared on the basis of the histor1 cosl convention in accordance wth the Financial ReportirFg Standard foi sMalr Enb"ties leffective April 20081 and wilh applicable Accounting Stsndards, the Accounting and Reports"ng by Charrties- Statement of Recommended Pwtice {SORP 2005) and the Charities Act 1993. Incomlng Resources Incoming resources are reported gross. Legacles and Donatlons Lega¢ies and donations are aCUnted for when the resources are receivable or when the charivs enlittement is enforceable. Lega¢*s weived in the fomi of property and investments are credrted at the ker of probate and market value. Other gifts in kind are included in the accounts at market value. Assets for distribution are recognised onty when distributed.. assets given for use by the charty are recognised when receivable" stocks of unsold donated goods are not valued for balance sheet purposes. Grants Receivable Grants are fecognised when receab. Dlre¢t Charitable Expenditure, Fund Raising. Management and Administratlon Direct charitable expenditure c(MnprÉ5es a51 expenditure direct relab"n9 to the objects of the charty. When ne$sary, costs afe alk)cated ben dire¢t ¢haritable expenditLEre fund-raising and management and ajmin1stratn on the basis of apportionment of the relevant expenditure. Lrfe Subscrfptlofis There are no lrfe subscripttons Commltments Commf(ments made by the directo that a legalty binding have been accrued. Those that are not alty binding have not been charged in the accounts, but disdosed in note11. Tangible Fixed Assets and Deprxiatton Tangible fixed assets are slated at cost. Deprectalion is provided ovw the expected useful INes of each category of tangible frxed asset as fotlows: F(Jrniture and Office Equipment 25% on net bwk value Plant and Equipment 25% on fiet b¢yJk valve Buildings Depreciated to reflect a valuation of £35000 Improvements lo Freehold Pioperty 2% on cost The Compressw Chamber and plev$ Improvements to Freehdd Property are fulty depreciated. Freehold Land has not been depreciated.
Solent Multiple Sclerosis Therapies Limited Notes to the Accounts For the Period Ended 31 March 2026 ACCOUNTING POUCIES Itinued) Stocks stocks aro valued at the of cost and net realtsable value after makirsg due allowance for any obsolete or sb)w-moving rtems. Cost inclLides diiecl materials, labour and overheads Incrred tn Pfoviding each seNce. Net realisable value is bas1 on esttmaled selling price less sdling costs. Ca$h Flow Statement The company has taken advantage of the exemption in the Financial Reporting Standard 1 from the fequirement lo disclose a Statement of Cash FEONS on the grounds that it 1$ a Sm1 company. INVESTMENT INCOME Mar-26 Mar-25 Bank Interest ReceivabEe 1,087 1.209 MANAGEMENT AND ADMINISTRATION Mar-26 Mar-25 Central Management and Admmistrat 98.369 99.763 ANALYSIS OF TOTAL RESOURCES EXPENDED Mar-26 Mar-25 Salaries Utilit$ Supplies DeprecialionlLoss on disposal 89.109 3.041 62,165 6.485 86.092 3.790 68.117 9,699 160.800 167.698 NET INCOMING RESOURCES Mar- Mar-25 This is slated after charging". DeprecialionlLoss on disposal 6.485 9,699
Solent Multiple Sclerosis Therapies Limited Notes to the Accounts For the Period Ended 31 March 2026 INTEREST PAYABLE LESS RECEIVABLE Mar46 Mar-25 Bank Interesl ReceNab 1.087 1,209 TAXATION No corporation tax is payable as the company is a registered ¢harty. TANGIBLE FIXED ASSETS Imp's to Freehokl Propety Com- Plant FurnilLFTè FreelK)Id presS)n and and Office Propety Chamber Equipment Equipment Total Cost Br<xJght Forward Additions Disposals Carried Forvrdrd 254.222 39.884 22,244 62.076 6,576 385.002 254.222 39,884 22,244 62.076 6.576 385.002 Depreciation Brought FoNord Charge for the year Eliminated on di5P'S Cauied FOnard 85,401 5.084 22,2*14 59.102 744 3.955 175.586 657 6,485 90.485 4.884 22,244 59,846 4,612 182,071 Net Book Value At 31.03.26 163.737 35,(N)O 2.230 1.964 202,931 At 31.03.25 168.821 35.000 2,974 2,621 209,416 The Improvements to Freehokl Propety represent the costs incurred for the major refurbishment of the Therapy Centre at Hewett Road, North End. Portsmouth. The works were completed in 2008. STOCK Mar-26 Mar-25 Goods for resale
Solent Multiple S¢lerosis Therapies Limited Notes to the Accounts For the Period Ended 31 March 2026 10 CREDITORS." AMOUNTS DUE WITHIN ONE YEAR Mar46 Mar-25 Taxation and s181 se¢urty Accruals Other creditors 1.354 2,309 172 3.835 1.779 3,667 2,836 8,282 11 LIMITED LIABIUTY Every member of the eompany undertakes lo Contribute to the assets ofthe company, in the event of the ¢panY being wound up. an amount not exceeding £1. 10
Solent Multiple Sclerosis Therapies Limited Summary Income and Expenditure Account For the Period Ended 31 March 2026 Mar-26 Mar-25 Income 133.593 156,311 133.593 156.311 Expenditure Oxygen Splints Salaries Building and Equipment Repairs and RenewaL8 11.445 9.519 89.109 9.324 3.041 12.900 6.032 606 14,056 5.877 1.925 86,092 12.860 3,790 12.367 4.512 537 20.410 6,612 1,300 General Office and Runniryj Costs Insltrance Premiums Diet Supplements,Vrtamins and G¢Jods for Resale Piovision of Physio and Tlapsts Fund Raising Expenses PTofessional Fees HMRC Penatty Depreciation 6.485 9,699 160.800 167.698 Net Surplusl(DefKitl for the Year 127,207) {11.387 11
Solent Multiple Sclerosis Therapies Limited Income Detail For the Period Ended 31 March 2026 Mar-26 Mar-25 Bank interest Book sales Iziffrti Bonus ball Collections Community events Corporate grants Direct debil donatsons EbayNintedlCharity Shop EPOIAPSIM8sks Gift aid HDOT donation Individijal donations Inductions Masons donkn.ons Membership National lottery grant Office bottles Physio donation PortsmoLtth lottery Reflex donations Solar panel payThent Sponsored events Trust donations 1.087 1.209 364 1.256 354 21.025 7,474 1,626 19,442 590 90 7.133 483 1,720 21.256 I,(2 2,533 60,576 3.883 2,200 3.162 63.430 4,695 3.358 8.302 7.454 3,262 7,804 277 7,060 1,670 2.299 2.0 7,952 260 7.767 1.484 70 133.693 1S6.311 12
Solent Multiple Sclerosis Therapies Limited Therapy Analysis For the Period Ended 31 March 2026 Surplusl {Deit} Donations Costs Physio 6,292 1,512 05teo Refflex 4,495 2,565 14.864 10.787 4.077 13
Solent Multtple Sclerosis Therapies Limited Bank Analysis For the Period Ended 31 March 2026 Mar-26 Mar-25 Lloyds TSB Current account 120.087 58,015 CAF Bank accounts CAFCash account Scottish Widows Bank 1.C69 Alr R9CgIvgr & Deluge Tank Fund HDOT Chamber emergency replacement reserve 87.215 Paypal 57 88 Total Bank Balances 120.144 146.387 Cash in hand 204 Total Bank and Cash 120,738 146,591 Balance per accounts 120,738 146,591 14
Solent Multiple Sclerosis Therapies Limited Fixed Assets For the Period Ended 31 March 2026 Imp's to Pknt Fymrture Freehold Freehdd presSn and and Offi Propety Property Chambw Equipmenl Equipment Total Cost 8rought Forward Additions Disposals Carried FoThvard 254.222 39.884 22.244 62.076 6,576 385,002 254.222 39,884 22,244 62.076 6,576 385.002 Depreciation Brought FOard Charge for the year Eliminated on disp's Carried FoThvard 85,401 5.084 4.884 22.244 59.102 744 3,955 175,586 657 6.485 90.485 4.884 22.244 59.846 4,612 182.071 Net Book Value At 31.03.26 163,737 35.000 2.230 1,964 202.931 At 31.03.25 168,821 35.000 2.974 2,621 209.416 15
Solent Multiple Sclerosis Therapies Limited Detailed In¢ome and Expenditure A¢count For the Period Ended 31 March 2026 Mar-26 Mar-25 Income 133.593 156.311 133.593 156.311 Direct Costs Fund Raising Costs Promsion of Physio and Therapists less contribution Oxygen less conlributton Splints EPO P8yroll Costs 5,877 6.612 14,056 14.056 20.410 11,445 11.445 9.519 606 89.109 537 86.092 121.093 12.500 123,170 33,141 Gross SuTpIu$ Overheads Building 3nd Equipment Repairs and Renth¥als 9.324 3,041 12.900 1.925 12.860 3.790 12,367 1,300 General Office and Running Costs Professional Fees HMRC Penalty DepreciationlLoss on disposal Insurance 6.485 6.032 9,699 4,512 39.707 44,528 Net SurplusllDeficitl for the year 27.207 11,387 Building and Equipment Repairs and Ren¢wals Repairs and Maintenance Buikling Chamber 6.039 3.285 9,324 8,745 4,115 12,860 General Offica and Running Costs Slaff Training Miscellaneous Telephone Postsge and Stationery Computer Costs Subs¢riptsons Bank charges Cleaning and Hygiene 1,022 1.103 819 708 4,223 480 323 3,689 12,367 500 620 5,183 400 254 5,139 12.900 16